Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
RSC Adv ; 13(38): 26794-26803, 2023 Sep 04.
Artigo em Inglês | MEDLINE | ID: mdl-37681050

RESUMO

The effects of microwave-assisted synthesis on the morphology and crystalline structure of WO3-graphene oxide (GO) composites have been investigated. Using two different microwave reactors, evidence supports that thermal and non-thermal effects significantly influence the properties of the synthesized materials. The findings reveal that the microwave cavity geometry affects how the microwaves are "delivered" to the reactional cavity as a function of time; it also orientates the growth process of the WO3 particles. Consequently, the crystalline structure and morphology are affected. As a result, the WO3-GO composites produced using a CEM reactor exhibit a rounded shape and hexagonal phase of WO3, besides enhanced reduction of GO. Whereas the composites made using an Anton-Paar reactor are composed of sheets and flowers of WO3 with hexagonal, triclinic and/or WO3 hydrate structures and cause a lower reduction on the GO.

2.
Trends Cardiovasc Med ; 31(5): 315-320, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-32535214

RESUMO

Whether influenza vaccination can play a prognostic role in patients with cardiovascular (CV) disease (coronary artery disease (CAD), heart failure, stroke, peripheral artery disease (PAD)) is still not completely well-established. We conducted this overview of systematic reviews (SR) evaluating the effects of influenza vaccination in secondary prevention of CV disease. An electronic search was performed in the MEDLINE (to November 2019). Eligibility criteria included SR evaluating the effect of influenza vaccination in patients with CV disease. The risk of bias of the included systematic reviews was evaluated using the ROBIS tool. All-cause mortality, CV mortality, major adverse cardiovascular events (MACE) and hospitalizations were evaluated. Whenever required, data were recalculated through a random-effects meta-analysis to obtain pooled data for the patients at secondary CV prevention. The search process yielded four SR: two in CAD, one in heart failure and one in stroke. There were no SR evaluating the vaccine in PAD. The risk of bias was unclear (2 SR) and high (2 SR). Influenza vaccination in patients with CAD showed a risk reduction in all-cause mortality (data recalculated), cardiovascular mortality and MACE, particularly in patients with recent acute coronary syndrome. In patients with heart failure, vaccination was associated with a decreased risk of all-cause mortality. There was a non-significant trend in recurrent stroke risk reduction in patients with previous stroke. The available evidence suggests that influenza vaccination was associated with a protective effect in CAD and HF patients. However, these results need to be clarified with higher quality evidence studies.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Vacinas contra Influenza/administração & dosagem , Influenza Humana/prevenção & controle , Prevenção Secundária , Vacinação , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/mortalidade , Humanos , Influenza Humana/diagnóstico , Influenza Humana/mortalidade , Medição de Risco , Fatores de Risco , Revisões Sistemáticas como Assunto , Resultado do Tratamento
3.
Nat Prod Res ; 31(22): 2599-2603, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28135874

RESUMO

A fungal strain of Aspergillus niger was recovered from sediments collected in the Northeast coast of Brazil (Pecém's offshore port terminal). Cultivation in different growth media yielded a new ester furan derivative, 1, along with malformin A1, malformin C, cyclo (trans-4-hydroxy-L-Pro-L-Leu), cyclo (trans-4-hydroxy-L-Pro-L-Phe), cyclo (L-Pro-L-Leu), cyclo (L-Pro-L-Phe), pseurotin D, pseurotin A, chlovalicin, cyclo (L-Pro-L-Tyr) and cyclo (L-Pro-L-Val). Compound 1 was cytotoxic against HCT-116 cell line, showing IC50 = 2.9 µg/mL (CI 95% from 1.8 to 4.7 µg/mL).


Assuntos
Antineoplásicos/farmacologia , Aspergillus niger/química , Antineoplásicos/química , Brasil , Cicloexanonas/isolamento & purificação , Cicloexanonas/farmacologia , Dipeptídeos/isolamento & purificação , Dipeptídeos/farmacologia , Ensaios de Seleção de Medicamentos Antitumorais , Compostos de Epóxi/isolamento & purificação , Compostos de Epóxi/farmacologia , Furanos/química , Sedimentos Geológicos/microbiologia , Células HCT116 , Humanos , Concentração Inibidora 50 , Espectroscopia de Ressonância Magnética , Estrutura Molecular , Peptídeos Cíclicos/química , Peptídeos Cíclicos/isolamento & purificação , Peptídeos Cíclicos/farmacologia , Pirrolidinonas/isolamento & purificação , Pirrolidinonas/farmacologia
4.
Chem Biodivers ; 12(3): 432-42, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25766916

RESUMO

The cytotoxic activities of extracts (50 µg/ml) from 48 fungal strains, recovered from sediments of Pecém's offshore port terminal (Northeast coast of Brazil), against HCT-116 colon cancer cell lines were investigated. The most promising extract was obtained from strain BRF082, identified as Dichotomomyces cejpii by phylogenetic analyses of partial RPB2 gene sequence. Thus, it was selected for bioassay-guided isolation of the cytotoxic compounds. Large-scale fermentation of BRF082 in potato dextrose broth, followed by chromatographic purification of the bioactive fractions from the liquid medium, yielded gliotoxin (4) and its derivatives acetylgliotoxin G (3), bis(dethio)bis(methylsulfanyl)gliotoxin (1), acetylgliotoxin (5), 6-acetylbis(dethio)bis(methylsulfanyl)gliotoxin (2), besides the quinazolinone alkaloid fiscalin B. All isolated compounds were tested for their cytotoxicities against the tumor cell lines HCT-116, revealing 4 and 3 as the most cytotoxic ones (IC50 0.41 and 1.06 µg/ml, resp.).


Assuntos
Antineoplásicos/química , Antineoplásicos/farmacologia , Produtos Biológicos/química , Produtos Biológicos/farmacologia , Fungos/química , Sedimentos Geológicos/microbiologia , Antineoplásicos/isolamento & purificação , Produtos Biológicos/isolamento & purificação , Brasil , Neoplasias do Colo/tratamento farmacológico , Fungos/genética , Gliotoxina/análogos & derivados , Gliotoxina/química , Gliotoxina/isolamento & purificação , Gliotoxina/farmacologia , Células HCT116 , Humanos , Indóis/química , Indóis/isolamento & purificação , Indóis/farmacologia , Filogenia , Quinazolinas/química , Quinazolinas/isolamento & purificação , Quinazolinas/farmacologia
5.
Nat Prod Res ; 29(16): 1545-50, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25532964

RESUMO

A fungal strain of Aspergillus sp. (BRF 030) was isolated from the sediments collected in the northeast coast of Brazil, and the cytotoxic activity of its secondary metabolites was investigated against HCT-116 tumour cell line. The cytotoxicity-guided fractionation of the extracts from this fungus cultured in potato-dextrose-sea water for 14 days at room temperature yielded the hetero-spirocyclic γ-lactams pseurotin A (1), pseurotin D (2) and pseurotin FD-838 (7), the alkaloids fumitremorgin C (5), 12,13-dihydroxy fumitremorgin C (6), methylsulochrin (4) and bis(dethio)bis(methylthio)gliotoxin (3). Among them, fumitremorgin C (5) and 12,13-dihydroxy fumitremorgin C (6) were the most active. The cytotoxic activities of the extracts from Aspergillus sp. grown from 7 to 28 days were investigated, and they were associated with the kinetic production of the compounds. The most active extracts (14 and 21 days) were those with the highest relative concentrations of the compounds fumitremorgin C (5) and 12,13-dihydroxy fumitremorgin C (6).


Assuntos
Antineoplásicos/química , Aspergillus/química , Antineoplásicos/isolamento & purificação , Aspergillus/isolamento & purificação , Brasil , Linhagem Celular Tumoral/efeitos dos fármacos , Sedimentos Geológicos/microbiologia , Humanos , Indóis/química , Indóis/isolamento & purificação , Estrutura Molecular , Água do Mar/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA